SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.
Zivojin JevticVittoria MataforaFrancesca CasagrandeFabio SantoroSaverio MinucciMassimilliano Garre'Milad RasouliOlaf HeidenreichGiovanna MuscoJürg SchwallerAngela BachiPublished in: Journal of experimental & clinical cancer research : CR (2022)
NUP98-NSD1 interacts and colocalizes on the genome with SMARCA5 which is an essential mediator of the NUP98-NSD1 transformation in hematopoietic cells. Formation of NUP98-NSD1 phase-separated nuclear condensates is not sufficient for the maintenance of transformed phenotype, which suggests that selective targeting of condensate constituents might represent a new therapeutic strategy for NUP98-NSD1 driven AML.